Description
Pembrolizumab is a type of targeted therapy drug called an immune checkpoint inhibitor (a type of immunotherapy). It is a monoclonal antibody that binds to the protein PD-1 on the surface of immune cells called T cells. It works by keeping cancer cells from suppressing the immune system. This allows the immune system to attack and kill the cancer cells.
Pembrolizumab is approved to treat:
- Biliary tract cancer
- Breast cancer
- Cervical cancer
- Classic Hodgkin lymphoma
- Cutaneous squamous cell carcinoma
- Endometrial carcinoma
- Esophageal or gastroesophageal junction cancer
- Gastric (stomach) cancer or gastroesophageal junction adenocarcinoma.
- Hepatocellular carcinoma
- Melanoma.
- Merkel cell carcinoma
- Microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) cancer
- Non-small cell lung cancer
- Primary mediastinal large B-cell lymphoma
- Renal cell carcinoma
- Solid tumors
- Squamous cell carcinoma of the head and neck
- Urothelial carcinoma
What is the process for submitting order request?
For more information or how to order branded-generic versions “Pembrolizumab Injection” manufactured by the pharmaceutical company in India. You can submit an online request or reach us on the given contact details, we will get back to you shortly.
We distribute a diverse range of pharmaceutical drugs, catering to the entirety of the pharmaceutical trade, which includes wholesale, tender supplies, orphan drugs, named patient access, biologics, biosimilars, and vaccines.
FAQs
Is branded-generic versions for Pembrolizumab Injection is available in India?
The branded-generic versions for Pembrolizumab Injection is available in India through Alleviare. For information on quality, pricing or bulk orders of branded-generic versions manufactured by the pharmaceutical company in India, please send us a message.
What is the price of Pembrolizumab Injection in India?
Pembrolizumab Injection price in India is reasonable and can vary. To procure Pembrolizumab Injection legally, you can call us at 9643240915 (Mr. Yashpal Singh) 9289711087 (Ms. Sana Sadyar), Or Write us at alleviare.exports@gmail.com or sana.sadyar@alleviareindia.com.
Do Alleviare Export Pembrolizumab Injection?
Yes Alleviare export Pembrolizumab Injection. Alleviare is one of the worldwide supplier of off patented drugs – Pembrolizumab Injection. It has wide range of pharma product range, about 15,000 different generic brands across 40 plus therapeutic categories. Alleviare can assist in the delivery of Pembrolizumab Injection; the doctor-prescribed medication to the Europe (such as UK, Hungary, Ireland, Latvia, Slovakia, Czech Republic, Belgium, Lithania, Greece, Spain, Maldova, Germany, Sweden, Italy, Bulgaria, Romania, Montenegro, Russia), Canada, UAE, Saudi Arabia, Kuwait, Qatar, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Australia, New Zealand, Philippines, the USA, Thailand, China, South Africa, Kazakhstan, Uzbekistan, Hong Kong, Zimbabwe, Zambia, Pakistan, Sri Lanka, Turkey, Afghanistan, Malaysia, Singapore, Japan, Nepal, and many other countries.
What steps should be followed to purchase Pembrolizumab Injection from ALS?
If you are looking generic brands for Pembrolizumab Injection in India. Please call us at +91 9643240915 (Mr. Yashpal Singh) +91 9289711087 (Ms. Sana Sadyar), Or Write us at alleviare.exports@gmail.com or sana.sadyar@alleviareindia.com. Our support team will be happy to assist you and answer any questions you may have.
Why do generic medicines often cost less than the brand-name medicines?
Generic drugs are approved only after a rigorous review by FDA and after a set period of time that the brand product has been on the market exclusively. This is because new drugs, like other new products, are usually protected by patents that prohibit others from making and selling copies of the same drug.
Generic drugs tend to cost less than their brand-name counterparts because generic drug applicants do not have to repeat animal and clinical (human) studies that were required of the brand-name medicines to demonstrate safety and effectiveness. This abbreviated pathway is why the application is called an “abbreviated new drug application.”
Reference :
www.fda.gov
Where can I find more information about generic medicines?
Contact your doctor, pharmacist, or other health care provider for information on generic medicines. For more information, you can also:
